Microquin LTD
Cambridge, MA Microquin, LTD.
- UEI
- UVZ4XT6GKZ36
- CAGE
- 88TQ6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 750 Main St, Cambridge, MA 02139, USA
- Website
- microquin.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Optimization of MIC compounds for the treatment of renal cell carcinomas | Defense Health Agency | $798,200 | |
| Development of a first-in-class small molecule to treat epithelial ovarian cancer | Defense Health Agency | $299,200 | |
| Creation of new chemical entities (nces) for treating traumatic brain injury | Defense Health Agency | $999,300 | |
| Development of a first-in-class gene therapeutic to treat non-small cell lung cancer (nsclc) | Defense Health Agency | $348,850 | |
| Development of first-in-class gene therapies to treat non-small cell lung cancer (nsclc) | Defense Health Agency | $97,268 |
About Microquin LTD
Microquin LTD is a for-profit biotechnology company headquartered in Cambridge, Massachusetts, that specializes in developing innovative therapeutic solutions for complex medical conditions. The company focuses on advancing gene therapies and small molecule treatments, positioning itself as a specialized research and development firm that collaborates with the federal government to address critical medical needs. Through federal grant awards, Microquin LTD provides research and development services in the biotechnology and pharmaceutical sectors, with a particular emphasis on oncology and neurological conditions affecting military service members and the broader population.
Microquin LTD has received seven prime federal grant awards totaling over $1.3 million from the Defense Health Agency and Department of the Army Medical Command, all funded through the Military Medical Research and Development program (CFDA 12.420). The company's research portfolio demonstrates a broad range of therapeutic development work, including development of first-in-class gene therapies for non-small cell lung cancer and acute myeloid leukemia, novel small molecule treatments for epithelial ovarian cancer, optimization of MIC compounds for renal cell carcinomas, and creation of new chemical entities for treating traumatic brain injury. Notably, Microquin LTD has leveraged multiple grants to advance similar therapeutic areas, indicating sustained federal investment in the company's research capabilities. The awards span from 2022 through 2027, with the most recent grants awarded in 2025 supporting ongoing oncology research. All grant awards have been performed at the company's Cambridge, Massachusetts location, and no subcontractor partnerships have been identified in the available award documentation.
Quick answers
What is Microquin LTD's UEI?
Microquin LTD's Unique Entity ID (UEI) in SAM.gov is UVZ4XT6GKZ36.
What is Microquin LTD's CAGE code?
Microquin LTD's CAGE code is 88TQ6.
What is Microquin LTD's primary NAICS code?
Microquin LTD's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Microquin LTD located?
Microquin LTD's physical address in SAM.gov is 750 Main St, Cambridge, MA 02139, USA.
Is Microquin LTD registered in SAM.gov?
Yes. Microquin LTD's SAM.gov registration is active through November 6, 2026.
What is Microquin LTD's most recent federal award?
Microquin LTD's most recent federal grant award is Optimization of MIC compounds for the treatment of renal cell carcinomas (HT94252510878), from Defense Health Agency, on November 1, 2025.
On GovTribe
See Microquin LTD's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors